CoChat

Niemann-Pick C1-Like 1 (NPC1L1) Inhibition and Cardiovascular Diseases

Open access
Pirillo, A., L. Catapano, A., D. Norata, G. · 2016 · Current Medicinal Chemistry

The DOI matches its Crossref record; 104 of the 104 references it cites were found in a registry or an index.

Abstract

Circulating levels of cholesterol are derived from either endogenous production or intestinal absorption of dietary and biliary cholesterol. Niemann-Pick C1-Like 1 (NPC1L1) is a transmembrane protein that plays a key role in the intestinal absorption of cholesterol by facilitating its uptake through vesicular endocytosis. NPC1L1 is the molecular target of ezetimibe which binds its extracellular loop and inhibits sterol absorption without affecting the absorption of other molecules. Ezetimibe significantly reduces plasma levels of total and low density lipoprotein cholesterol (LDL-C) as monotherapy or when added to statins, the association with a low dose of statin is of particular interest for patients experiencing statin-related side effects. The recent results of the IMPROVE-IT study, which evaluated the cardiovascular effect of ezetimibe added to simvastatin therapy in subjects who had had an acute coronary syndrome and with LDL-C levels within the recommended range, showed that a further LDL-C lowering reduced the incidence of cardiovascular events. To date, ezetimibe represents the only inhibitor of NPC1L1 available for clinical use, however, novel aminoß- lactam ezetimibe derivatives have been synthesized and their efficacy to inhibit NPC1L1 protein and decrease plasma cholesterol levels is under evaluation.

Overview

Integrity signals

Registry

Crossref · 10.2174/0929867323666160229114111

Cites

104 of 104 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Citations

Cites

Show all 104 references

Cited by

See all 46

Metadata

Authors
Pirillo, A., L. Catapano, A., & D. Norata, G.
Venue
Current Medicinal Chemistry
Published
2016-04-07
Volume
23
Issue
10
Pages
983-999
ISSN
0929-8673 (ISSN-L)
OpenAlex
W2288779759
Cited by
45
References
104
Citations by year
2026: 3 · 2025: 5 · 2024: 10 · 2023: 7 · 2022: 6 · 2021: 5 · 2020: 1 · 2019: 5 · 2017: 2 · 2016: 1
FWCI
2.95
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • Current Medicinal Chemistry (publishedVersion)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
  • eSpace (Curtin University) (submittedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Keywords
NPC1L1, ezetimibe, cholesterol absorption, LDL cholesterol lowering, cardiovascular disease, IMPROVE-IT trial, statin intolerance, sterol transporters
MeSH terms
Ezetimibe, Cardiovascular Diseases, Humans, Membrane Proteins, Simvastatin, Membrane Transport Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Niemann-Pick C1-Like 1 (NPC1L1) Inhibition and Cardiovascular Diseases. https://app.cochat.ai/papers/10.2174/0929867323666160229114111
The paper
Pirillo, A., L. Catapano, A., & D. Norata, G. (2016). Niemann-Pick C1-Like 1 (NPC1L1) Inhibition and Cardiovascular Diseases. Current Medicinal Chemistry. https://doi.org/10.2174/0929867323666160229114111

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.